Suppliers / Tianish Laboratories

Tianish Laboratories

India Updated 9 July 2026

Tianish Laboratories is an API manufacturer based in India. It holds 2 active US drug master files and 6 valid CEPs across a filed portfolio of 8 molecules. Customs aggregates show $136.4M of exports covering 1,015 molecules to 65 destinations in 2025.

2
active US DMFs
6
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Hyderabad, India Not on file

What they file, and where

Molecule Regulators Docs
Citalopram EDQM 2
Carvedilol EDQM 1
Cobicistat US FDA 1
Levofloxacin EDQM 1
Octreotide EDQM 1
Pretomanid US FDA 1
Valaciclovir SFDA (Saudi Arabia) 1
Voriconazole EDQM 1

Also appears on these molecule pages

Carvedilol API Citalopram API Cobicistat API Valaciclovir API Valacyclovir API Levofloxacin API Voriconazole API Octreotide API

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $5.9M 20
2025 Not reported $136.4M 65
2024 Not reported $77.5M 58

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Tianish Laboratories

Does Tianish Laboratories hold a US DMF or a CEP?
Tianish Laboratories holds 2 active US drug master files and 6 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Tianish Laboratories manufacture?
1 registered site is on record, in India (Hyderabad). Every site is listed on this page with the register it came from.
What does Tianish Laboratories make?
8 molecules are on record against Tianish Laboratories, including Citalopram, Carvedilol, Cobicistat and Levofloxacin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Tianish Laboratories comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Matrix Pharmacorp shares 5 molecules Apitoria Pharma shares 4 molecules Cipla shares 4 molecules Hetero shares 3 molecules Zydus Lifesciences shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts